US hospital group Agreement

Surgical Innovations Group PLC
18 December 2006




Press Release                                                   18 December 2006

                         Surgical Innovations Group plc

                          ('Surgical' or 'the Group')

               Provider of Choice for major US hospital group


Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of
innovative surgical devices, today announces that it has been approved by the
North Shore Long Island Jewish Health System ('North Shore') as an accredited
supplier of laparoscopic equipment.

Following extensive trials across all disciplines of laparoscopic surgery within
the North Shore hospital group, the Group's market-leading 'resposable' (a
mixture of both reusable and disposable items) and versatile YelloPort abdominal
access system will be supplied to operating theatres in pre-prepared equipment
trays, tailored to each type of operation.

North Shore is the USA's third-largest non-profit secular healthcare systems
group, comprising 15 hospitals, with in excess of 6,000 beds.  With a US$4
billion annual operating budget and more than 38,000 employees, North Shore
services an area of 5.2 million people in New York State.

North Shore treats more than 235,000 in-patients annually and offers a full
spectrum of advanced minimally invasive procedures.  There are 4.4 million
laparoscopic surgical procedures carried out each year in the US (Source:
Patient Safety and Quality Healthcare journal, May/June 2005) and the worldwide
demand for such operations is escalating with the majority of countries now
undertaking these procedures on a routine basis.

Graham Bowland, Joint Managing Director of Surgical Innovations, commented:  'We
are delighted to have been accredited by North Shore and look forward to further
opportunities to demonstrate our range of surgical instruments.  We believe this
is a positive step in the growth of the Group and are confident that this
invaluable endorsement from pre-eminent surgeons at a respected hospital group
will help us gain accredited supplier status in further hospitals across the
USA.'


                                    - Ends -

For further information:
 Surgical Innovations Group plc
 Graham Bowland, Managing Director                     Tel: [phone]
 [e-mail]                                www.sigroupplc.com

 Hanson Westhouse LLP
 Tim Feather                                           Tel: [phone]
 [e-mail]                         www.hansonwesthouse.com


Media enquiries:
 Abchurch
 Gareth Mead / Justin Heath                            Tel: [phone]
 [e-mail]                           www.abchurch-group.com



Notes to Editors:

Surgical Innovations Group plc specialises in the design and manufacture of
innovative devices for use in minimally invasive surgery and industrial markets.
  The Group employs over 50 people and is headquartered in Leeds.

The Group's medical division is focused on strong international growth in two
specialist areas namely minimally invasive surgery, where products are used in
'keyhole' surgery which is more accurately known as laparoscopic surgery, and
products for autologous blood transfusion whereby a patient's own blood is
recycled.

The Group's industrial division utilises Surgical Innovations' core medical
device design expertise and technology in innovative engineering applications.

For more information, see www.sigroupplc.com




                      This information is provided by RNS
            The company news service from the London Stock Exchange